BioSpace News Archive

Transparency Market Research has published a new report on the HIV/AIDS diagnostics market for the forecast period of 2019–2027.

Transparency Market Research has recently published a new research report that talks about the overall landscape of the global empty capsules market.

NeonMind Biosciences Inc. announced today the appointment of Dr. Daniel Bainbridge, MD, FRCPC, past President of the Canadian Anesthesiologists Society.

Avaneer Health today announced several industry-leading organizations have committed a total of $50 million in seed funding to the venture.

Today, leading global health and wellness agency, Evoke , announced three key leadership hires to its executive team.

The U.S. Food and Drug Administration released a white paper developed by the Interagency Working Group on Asbestos in Consumer Products that contains scientific opinions for the testing of talc-containing cosmetics and talc intended for use in cosmetics for the possible presence of asbestos, a known human carcinogen with well-documented health risks.

Bluejay Diagnostics, Inc. today reported that it has completed 90 subjects in the prospective multicenter clinical study addressing rapid IL-6 test for COVID-19 patients with critical care.

Medable Inc., the leading cloud platform for patient-centered drug development, today announced results from a Tufts CSDD analysis which shows that, on average, decentralized clinical trials (DCTs) are associated with reduced clinical trial timelines and can achieve net financial benefits ranging from five to 14 times for Phase II and Phase III trials, respectively.

According to Emergen Research, the global virtual diagnostics market size was USD 565.11 million in 2020 and is expected to reach USD 1,739.03 million in 2028 and register a revenue CAGR of 15.0% during the forecast period, 2021-2028.

MaaT Pharma, a French clinical-stage biotech and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving survival outcomes for patients with cancer, announces the initiation of coverage of its stock by KBC Securities, Kempen and Portzamparc / Groupe BNP Paribas.